Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

Clear filters
ClinicalTrials.gov public records Last synced Sep 7, 2026, 5:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–2 of 2 matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
Filters: Intervention: CAN1012 Clear all
Not yet recruiting Phase 1 Interventional

CAN1012 in Pre-Malignant DCIS and LCIS

NCT07408856
View directory record Official record
Conditions
Ductal Carcinoma in Situ, Lobular Carcinoma in Situ
Interventions
CAN1012
Drug
Lead sponsor
Providence Health & Services
Other
Eligibility
18 Years and older
Enrollment
24 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2035
U.S. locations
1
States / cities
Portland, Oregon
Source: ClinicalTrials.gov public record
Updated Jul 22, 2026 · Synced Sep 7, 2026, 5:36 AM EDT
Not listed Phase 1 Interventional

Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors

NCT04987112
View directory record Official record
Conditions
Solid Tumor, Cancer Metastatic
Interventions
CAN1012
Drug
Lead sponsor
CanWell Pharma Inc.
Industry
Eligibility
18 Years to 80 Years
Enrollment
36 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2022 – 2024
U.S. locations
2
States / cities
Woburn, Massachusetts • Portland, Oregon
Source: ClinicalTrials.gov public record
Updated Dec 21, 2023 · Synced Sep 7, 2026, 5:36 AM EDT